查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1726379

全球综合代谢组检测市场：市场规模、份额、趋势分析（按分析目标、疾病、最终用途和地区）、细分市场预测（2025 年至 2030 年）

Comprehensive Metabolic Panel Testing Market Size, Share & Trends Analysis Report By Analytes (K+, Na+, Cl-, CO2), By Disease (Kidney Disease, Diabetes), By End-use (Laboratory, PoC), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

综合代谢组测试市场的成长与趋势：

根据 Grand View Research, Inc. 的新报告，全球综合代谢组测试市场预计到 2030 年将达到 220.7 亿美元，2025 年至 2030 年的复合年增长率为 9.5%。

糖尿病、肾臟疾病和心血管疾病等慢性疾病负担的增加是市场成长的主要驱动力。

技术创新正在再形成诊断能力，自动化平台和照护现场设备提高了检测速度、准确性和可访问性。先进的系统现在正在整合人工智慧进行数据分析，从而能够准确解释结果和预测见解。

此外，预防保健意识的不断增强正在改变医疗保健消费模式。公共卫生宣传活动和政策倡议强调早期疗育以控制长期成本，并鼓励个人优先进行定期METABOLIC INC.筛检。保险公司越来越多地将这些测试作为预防性护理计划的一部分，从而增加了采用率。

综合代谢组测试市场：分析概述

  • 预计 2024 年葡萄糖的销售份额最大，为 11.0%。这是因为人们更重视早期发现和预防护理，以及久坐的生活方式和不良饮食等生活方式相关因素。
  • 由于肾臟疾病、心血管疾病和电解质失衡病例的增加需要准确监测 K+ 水平，预计预测期内 K+ 部分将以 10.0% 最快的复合年增长率增长。
  • 肾臟疾病将在全球综合代谢组检测市场中占据主导地位，到 2024 年将占据 32.4% 的最大收入份额。这主要是由于高血压、糖尿病和肥胖症的发生率不断上升，以及污染和过量摄取等环境因素。
  • 由于技术进步使得检测更加准确和便捷，以及医疗保险对预防性筛检的覆盖范围不断扩大，糖尿病领域预计将以最快的速度增长，预测期内的复合年增长率为 10.3%。
  • 到 2024 年，实验室领域将在收益占有率方面占据最大的市场主导地位。预计 PoC 领域将成长最快，2025 年至 2030 年的复合年增长率为 10.3%。
  • 预计到 2024 年，北美将占据全球综合代谢组检测市场的最大收入份额，这主要是因为糖尿病、肾臟疾病和心血管疾病等慢性疾病的收益占有率很高，需要进行常规代谢监测。
  • 全球综合代谢组测试市场的一些主要企业包括雅培、Quest Diagnostics、Sonic Healthcare、Unipath、SYNLAB International GmbH 和 ARUP Laboratories。

目录

第一章 分析方法与范围

第二章执行摘要

第三章全球综合代谢组测试市场：驱动因素、趋势与范围

  • 市场联动展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制分析
  • 综合代谢组测试市场：分析工具
    • 产业分析：波特五力分析
    • PESTEL分析

第四章全球综合代谢组测试市场：按分析类别的商业分析

  • 每个分析目标的仪表板
  • 综合代谢组检测市场：依分析目标进行变异分析
  • 全球综合代谢组测试市场：按分析类型分類的市场规模和趋势分析（2018-2030 年）
  • K+
  • 钠
  • Cl-
  • CO2
  • 葡萄糖
  • 麵包
  • 肌酸酐
  • 钙
  • 白蛋白
  • 总蛋白
  • ALP
  • 选择
  • AST
  • 总胆红素

第五章全球综合代谢组测试市场：按疾病分類的业务分析

  • 疾病仪表板
  • 综合代谢组检测市场：依疾病进行变异分析
  • 全球综合代谢组检测市场：按疾病分類的市场规模和趋势分析（2018-2030 年）
  • 肾臟疾病
  • 肝病
  • 糖尿病
  • 其他的

6. 全球综合代谢组测试市场：依最终用途的业务分析

  • 最终用途仪表板
  • 综合代谢组检测市场：变异分析（依最终用途）
  • 全球综合代谢组测试市场：按最终用途分類的市场规模和趋势分析（2018-2030 年）
  • 实验室
  • 概念验证
  • PoC（设备）

第七章全球综合代谢组测试市场：按地区估计和趋势分析

  • 市场仪表板：按地区
  • 各地区市场占有率分析（2024 年及 2030 年）
  • 全球综合代谢组检测市场：按地区分類的关键要点
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
  • 供应商格局
    • 主要企业热力图分析（2024年）
  • 公司简介
    • Abbott
    • Quest Diagnostics
    • Laboratory Corporation of America Holdings Limited
    • Sonic Healthcare
    • Unipath
    • SYNLAB International GmbH
    • ARUP Laboratories
    • Genoptix Inc.
    • Nova Medical
Product Code: GVR-3-68038-747-6

Comprehensive Metabolic Panel Testing Market Growth & Trends:

The global comprehensive metabolic panel testing market is anticipated to reach USD 22.07 billion by 2030 and is expected to expand at a CAGR of 9.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising burden of chronic conditions such as diabetes, kidney disorders, and cardiovascular ailments is the major factor contributing to the market's growth.

Technological innovations are reshaping diagnostic capabilities, with automated platforms and point-of-care devices enhancing testing speed, accuracy, and accessibility. Advanced systems now integrate AI for data analysis, allowing precise interpretation of results and predictive insights.

Moreover, heightened awareness of preventive care is transforming healthcare consumption patterns. Public health campaigns and policy initiatives emphasize early intervention to curb long-term costs, prompting individuals to prioritize regular metabolic screenings. Insurers are increasingly covering these tests within preventive care packages, reinforcing their adoption.

Comprehensive Metabolic Panel Testing Market Report Highlights:

  • Glucose accounted for the largest revenue share of 11.0% in 2024, attributed to the increased emphasis on early detection and preventive healthcare, coupled with lifestyle-related factors such as sedentary habits and poor diets.
  • The K+ segment is expected to grow at the fastest CAGR of 10.0% over the forecast period, owing to rising cases of kidney diseases, cardiovascular disorders, and electrolyte imbalances requiring precise monitoring of K+ levels.
  • The kidney diseases dominated the global comprehensive metabolic panel testing market and accounted for the largest revenue share of 32.4% in 2024, primarily driven by increased incidence of hypertension, diabetes, and obesity, alongside environmental factors such as pollution and dietary salt overconsumption.
  • The diabetes segment is expected to grow at the fastest CAGR of 10.3% over the forecast period, due to technological advancements enabling precise, accessible testing and expanded health insurance coverage for preventive screenings
  • The laboratories segment held the dominant position in the market with the largest revenue share in 2024. The PoC segment is expected to grow at the fastest CAGR of 10.3% from 2025 to 2030.
  • North America dominated the global comprehensive metabolic panel testing market with the largest revenue share in 2024, primarily driven by the high prevalence of chronic diseases such as diabetes, kidney disorders, and cardiovascular conditions, necessitating routine metabolic monitoring.
  • Key companies operating in the global comprehensive metabolic panel testing market include Abbott, Quest Diagnostics, Sonic Healthcare, Unipath, SYNLAB International GmbH, ARUP Laboratories.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Analytes
    • 1.2.2. Disease
    • 1.2.3. End Use
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Analytes Outlook
    • 2.2.2. Disease Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Comprehensive Metabolic Panel Testing Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Global Comprehensive Metabolic Panel Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political Landscape
      • 3.3.2.2. Technological Landscape
      • 3.3.2.3. Economic Landscape

Chapter 4. Global Comprehensive Metabolic Panel Testing Market: Analytes Business Analysis

  • 4.1. Analytes Segment Dashboard
  • 4.2. Comprehensive Metabolic Panel Testing Market: Analytes Movement Analysis
  • 4.3. Global Comprehensive Metabolic Panel Testing Market Size & Trend Analysis, By Analytes, 2018 to 2030 (USD Million)
  • 4.4. K+
    • 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.5. Na+
    • 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.6. Cl-
    • 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.7. CO2
    • 4.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.8. Glucose
    • 4.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.9. BUN
    • 4.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.10. Creatinine
    • 4.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.11. Ca++
    • 4.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.12. Albumin
    • 4.12.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.13. Total protein
    • 4.13.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.14. ALP
    • 4.14.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.15. ALT
    • 4.15.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.16. AST
    • 4.16.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 4.17. Total bilirubin
    • 4.17.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 5. Global Comprehensive Metabolic Panel Testing Market: Disease Business Analysis

  • 5.1. Disease Segment Dashboard
  • 5.2. Comprehensive Metabolic Panel Testing Market: Disease Movement Analysis
  • 5.3. Global Comprehensive Metabolic Panel Testing Market Size & Trend Analysis, By Disease, 2018 to 2030 (USD Million)
  • 5.4. Kidney Disease
    • 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.5. Liver Disease
    • 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.6. Diabetes
    • 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 6. Global Comprehensive Metabolic Panel Testing Market: End Use Business Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. Comprehensive Metabolic Panel Testing Market: End Use Movement Analysis
  • 6.3. Global Comprehensive Metabolic Panel Testing Market Size & Trend Analysis, By End Use, 2018 to 2030 (USD Million)
  • 6.4. Laboratory
    • 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Emergency dept.
      • 6.4.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Hospital wards
      • 6.4.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Primary care
      • 6.4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Pharmacy
      • 6.4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Telemedicine
      • 6.4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.5. PoC
    • 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Emergency dept.
      • 6.5.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.3. Hospital wards
      • 6.5.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Primary care
      • 6.5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.5. Pharmacy
      • 6.5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Telemedicine
      • 6.5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 6.6. PoC (Instruments)
    • 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Piccolo Xpress
      • 6.6.2.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.3. Skyla-HB1
      • 6.6.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.4. DRI-CHEM NX500
      • 6.6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 6.6.5. Others
      • 6.6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 7. Global Comprehensive Metabolic Panel Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Dashboard
  • 7.2. Regional Market Share Analysis, 2024 & 2030
  • 7.3. Global Comprehensive Metabolic Panel Testing Market by Region: Key Takeaways
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key Country Dynamics
      • 7.4.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.1.3. Competitive Scenario
      • 7.4.1.4. U.S. Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key Country Dynamics
      • 7.4.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.2.3. Competitive Scenario
      • 7.4.2.4. Canada Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Mexico Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Germany
      • 7.5.1.1. Key Country Dynamics
      • 7.5.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.1.3. Competitive Scenario
      • 7.5.1.4. Germany Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. Key Country Dynamics
      • 7.5.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.2.3. Competitive Scenario
      • 7.5.2.4. UK Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. France Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Italy Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Spain Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Denmark
      • 7.5.6.1. Key Country Dynamics
      • 7.5.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.6.3. Competitive Scenario
      • 7.5.6.4. Denmark Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key Country Dynamics
      • 7.5.7.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.7.3. Competitive Scenario
      • 7.5.7.4. Sweden Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Norway
      • 7.5.8.1. Key Country Dynamics
      • 7.5.8.2. Regulatory Framework/ Reimbursement Structure
      • 7.5.8.3. Competitive Scenario
      • 7.5.8.4. Norway Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key Country Dynamics
      • 7.6.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.1.3. Competitive Scenario
      • 7.6.1.4. Japan Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key Country Dynamics
      • 7.6.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.2.3. Competitive Scenario
      • 7.6.2.4. China Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. India Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Australia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Thailand
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Thailand Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Regulatory Framework/ Reimbursement Structure
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. South Korea Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key Country Dynamics
      • 7.7.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.1.3. Competitive Scenario
      • 7.7.1.4. Brazil Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key Country Dynamics
      • 7.7.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.7.2.3. Competitive Scenario
      • 7.7.2.4. Argentina Market Estimates and Forecasts 2018 to 2030 (USD Million)
  • 7.8. Middle East & Africa
    • 7.8.1. South Africa
      • 7.8.1.1. Key Country Dynamics
      • 7.8.1.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.1.3. Competitive Scenario
      • 7.8.1.4. South Africa Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key Country Dynamics
      • 7.8.2.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.2.3. Competitive Scenario
      • 7.8.2.4. South Arabia Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key Country Dynamics
      • 7.8.3.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.3.3. Competitive Scenario
      • 7.8.3.4. UAE Market Estimates and Forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key Country Dynamics
      • 7.8.4.2. Regulatory Framework/ Reimbursement Structure
      • 7.8.4.3. Competitive Scenario
      • 7.8.4.4. Kuwait Market Estimates and Forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. Key Company Heat Map Analysis, 2024
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Strategic Initiatives
    • 8.4.2. Quest Diagnostics
      • 8.4.2.1. Company Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Strategic Initiatives
    • 8.4.3. Laboratory Corporation of America Holdings Limited
      • 8.4.3.1. Company Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Strategic Initiatives
    • 8.4.4. Sonic Healthcare
      • 8.4.4.1. Company Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Strategic Initiatives
    • 8.4.5. Unipath
      • 8.4.5.1. Company Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Strategic Initiatives
    • 8.4.6. SYNLAB International GmbH
      • 8.4.6.1. Company Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Strategic Initiatives
    • 8.4.7. ARUP Laboratories
      • 8.4.7.1. Company Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Strategic Initiatives
    • 8.4.8. Genoptix Inc.
      • 8.4.8.1. Company Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Strategic Initiatives
    • 8.4.9. Nova Medical
      • 8.4.9.1. Company Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Strategic Initiative

List of Tables

  • Table 1 List Of Abbreviations
  • Table 2 Global Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 3 Global Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 4 Global Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 5 Global Comprehensive Metabolic Panel Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 6 North America Comprehensive Metabolic Panel Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 7 North America Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 8 North America Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 9 North America Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 11 U.S. Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 12 U.S. Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 13 Canada Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 14 Canada Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 15 Canada Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 16 Mexico Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 17 Mexico Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 18 Mexico Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 19 Europe Comprehensive Metabolic Panel Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 21 Europe Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 22 Europe Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 23 Germany Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 24 Germany Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 25 Germany Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 26 UK Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 27 UK Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 28 UK Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 29 France Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 30 France Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 31 France Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 32 Italy Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 33 Italy Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 34 Italy Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 35 Spain Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 36 Spain Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 37 Spain Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 38 Denmark Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 39 Denmark Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 40 Denmark Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 41 Sweden Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 42 Sweden Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 43 Sweden Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 44 Norway Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 45 Norway Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 46 Norway Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Comprehensive Metabolic Panel Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 51 China Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 52 China Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 53 China Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 54 Japan Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 55 Japan Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 56 Japan Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 57 India Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 58 India Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 59 India Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 60 South Korea Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 61 South Korea Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 62 South Korea Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 63 Australia Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 64 Australia Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 65 Australia Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 66 Thailand Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 67 Thailand Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 68 Thailand Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 69 Latin America Comprehensive Metabolic Panel Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 71 Latin America Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 72 Latin America Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 73 Brazil Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 74 Brazil Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 75 Argentina Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 76 Argentina Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 77 Argentina Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 78 MEA Comprehensive Metabolic Panel Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 79 MEA Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 80 MEA Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 81 MEA Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 82 South Africa Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 83 South Africa Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 84 South Africa Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 88 UAE Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 89 UAE Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 90 UAE Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Comprehensive Metabolic Panel Testing Market, By Analytes, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Comprehensive Metabolic Panel Testing Market, By Disease, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Comprehensive Metabolic Panel Testing Market, By End Use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Data Triangulation Techniques
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Primary Interviews
  • Fig. 5 Market Research Approaches
  • Fig. 6 Value-Chain-Based Sizing & Forecasting
  • Fig. 7 QFD Modeling for Market Share Assessment
  • Fig. 8 Market Formulation & Validation
  • Fig. 9 Comprehensive Metabolic Panel Testing Market: Market Outlook
  • Fig. 10 Comprehensive Metabolic Panel Testing Competitive Insights
  • Fig. 11 Parent Market Outlook
  • Fig. 12 Related/Ancillary Market Outlook
  • Fig. 13 Penetration and Growth Prospect Mapping
  • Fig. 14 Industry Value Chain Analysis
  • Fig. 15 Comprehensive Metabolic Panel Testing Market Driver Impact
  • Fig. 16 Comprehensive Metabolic Panel Testing Market Restraint Impact
  • Fig. 17 Comprehensive Metabolic Panel Testing Market Strategic Initiatives Analysis
  • Fig. 18 Comprehensive Metabolic Panel Testing Market: Analytes Movement Analysis
  • Fig. 19 Comprehensive Metabolic Panel Testing Market: Analytes Outlook and Key Takeaways
  • Fig. 20 K+ Market Estimates and Forecast, 2018 - 2030
  • Fig. 21 Na+ Market Estimates and Forecast, 2018 - 2030
  • Fig. 22 Cl- Market Estimates and Forecast, 2018 - 2030
  • Fig. 23 CO2 Market Estimates and Forecast, 2018 - 2030
  • Fig. 24 Glucose Market Estimates and Forecast, 2018 - 2030
  • Fig. 25 BUN Market Estimates and Forecast, 2018 - 2030
  • Fig. 26 Creatinine Market Estimates and Forecast, 2018 - 2030
  • Fig. 27 Ca++ Market Estimates and Forecast, 2018 - 2030
  • Fig. 28 Albumin Market Estimates and Forecast, 2018 - 2030
  • Fig. 29 Total protein Market Estimates and Forecast, 2018 - 2030
  • Fig. 30 ALP Market Estimates and Forecast, 2018 - 2030
  • Fig. 31 ALT Market Estimates and Forecast, 2018 - 2030
  • Fig. 32 AST Market Estimates and Forecast, 2018 - 2030
  • Fig. 33 Total bilirubin Market Estimates and Forecast, 2018 - 2030
  • Fig. 34 Comprehensive Metabolic Panel Testing Market: Disease Movement Analysis
  • Fig. 35 Comprehensive Metabolic Panel Testing Market: Disease Outlook and Key Takeaways
  • Fig. 36 Kidney Disease Market Estimates and Forecasts, 2018 - 2030
  • Fig. 37 Liver Disease Market Estimates and Forecasts, 2018 - 2030
  • Fig. 38 Diabetes Market Estimates and Forecasts, 2018 - 2030
  • Fig. 39 Others Market Estimates and Forecasts, 2018 - 2030
  • Fig. 40 Comprehensive Metabolic Panel Testing Market: End Use Movement Analysis
  • Fig. 41 Comprehensive Metabolic Panel Testing Market: End Use Outlook and Key Takeaways
  • Fig. 42 Laboratory Market Estimates and Forecasts, 2018 - 2030
  • Fig. 43 PoC Market Estimates and Forecasts, 2018 - 2030
  • Fig. 44 PoC (Instruments) Market Estimates and Forecasts, 2018 - 2030
  • Fig. 45 Global Comprehensive Metabolic Panel Testing Market: Regional Movement Analysis
  • Fig. 46 Global Comprehensive Metabolic Panel Testing Market: Regional Outlook and Key Takeaways
  • Fig. 47 North America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 48 U.S. Market Estimates and Forecasts, 2018 - 2030
  • Fig. 49 Canada Market Estimates and Forecasts, 2018 - 2030
  • Fig. 50 Mexico Market Estimates and Forecasts, 2018 - 2030
  • Fig. 51 Europe Market Estimates and Forecasts, 2018 - 2030
  • Fig. 52 UK Market Estimates and Forecasts, 2018 - 2030
  • Fig. 53 Germany Market Estimates and Forecasts, 2018 - 2030
  • Fig. 54 France Market Estimates and Forecasts, 2018 - 2030
  • Fig. 55 Italy Market Estimates and Forecasts, 2018 - 2030
  • Fig. 56 Spain Market Estimates and Forecasts, 2018 - 2030
  • Fig. 57 Denmark Market Estimates and Forecasts, 2018 - 2030
  • Fig. 58 Sweden Market Estimates and Forecasts, 2018 - 2030
  • Fig. 59 Norway Market Estimates and Forecasts, 2018 - 2030
  • Fig. 60 Asia Pacific Market Estimates and Forecasts, 2018 - 2030
  • Fig. 61 China Market Estimates and Forecasts, 2018 - 2030
  • Fig. 62 Japan Market Estimates and Forecasts, 2018 - 2030
  • Fig. 63 India Market Estimates and Forecasts, 2018 - 2030
  • Fig. 64 Thailand Market Estimates and Forecasts, 2018 - 2030
  • Fig. 65 South Korea Market Estimates and Forecasts, 2018 - 2030
  • Fig. 66 Australia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 67 Latin America Market Estimates and Forecasts, 2018 - 2030
  • Fig. 68 Brazil Market Estimates and Forecasts, 2018 - 2030
  • Fig. 69 Argentina Market Estimates and Forecasts, 2018 - 2030
  • Fig. 70 Middle East and Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 71 South Africa Market Estimates and Forecasts, 2018 - 2030
  • Fig. 72 Saudi Arabia Market Estimates and Forecasts, 2018 - 2030
  • Fig. 73 UAE Market Estimates and Forecasts, 2018 - 2030
  • Fig. 74 Kuwait Market Estimates and Forecasts, 2018 - 2030